Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Organotypic Platform for Therapeutic Investigation (OPTin) for Guiding Cancer Patients Treatment
Clinical trial update describing the OPTin organotypic platform to guide treatment decisions for patients with solid tumors/cancer, currentl…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors [Phase 1]
BeiGene is conducting a Phase 1 study of BG-T187 both alone and in combination with other agents for advanced solid tumors, and recruitment …
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies [Phase 1, Phase 2]
A Phase 1/Phase 2 study of AZD9574 as a monotherapy and in combination with anti-cancer agents is underway in participants with advanced sol…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: DCSZ11 in Combination With Standard Therapy in Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 trial evaluating DCSZ11 in combination with standard therapy for advanced or metastatic solid tumors is currently recruiting. Th…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
DT-7012 is being studied as a single agent and in combination with an immune checkpoint inhibitor in a Phase 1/2 trial for advanced solid tu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: A Novel Molecular Approach to Blood DNA Screening for Cancer: Specificity Assessment (The NOMAD Study)
The NOMAD study at Mayo Clinic is evaluating a novel blood DNA screening approach for cancer, currently recruiting to assess test specificit…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors [Phase 1]
A Phase 1 trial evaluating the combination of dasatinib, temsirolimus, and cyclophosphamide for advanced malignant solid tumors and recurren…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors [Phase 1]
Phase 1 trial of ALTA2618 for AKT1 E17K-mutant solid tumors is currently recruiting, with breast cancer and endometrial cancer among the ind…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors [Phase 1]
Phase 1 trial evaluating NEROFE in combination with doxorubicin for KRAS-mutant ST2-positive solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Palliative Spatially Fractionated (GRID) Radiotherapy Using Intensity Modulated Proton Therapy [NA]
A clinical trial from Washington University tests palliative GRID radiotherapy using intensity-modulated proton therapy for unresectable sol…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 study is evaluating PYX-201 in combination with pembrolizumab for advanced solid tumors; the trial is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Advanced or Recurrent Solid Tumors Treated With SHetA2 [Phase 1]
A Phase 1 clinical trial evaluating SHetA2 in adults with advanced or recurrent solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Patient Reported Symptom Control With THC or CBD Use
This clinical trial update discusses patient-reported symptom control with tetrahydrocannabinol (THC) or cannabidiol (CBD) in cancer patient…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A Phase 1, Open-label, Multicenter, Dose Escalation Study of IBI363 (PD1-IL2m) in Subjects With Advanced Solid Malignancies or Lymphomas [Phase 1]
Phase 1, open-label, multicenter dose-escalation study of IBI363 (PD1-IL2m) in adults with advanced solid tumors or lymphomas; trial status …
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: SB-4826 in Adult Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphomas [Phase 1, Phase 2]
Clinical trial update for SB-4826 in adults with locally advanced or metastatic solid tumors or non-Hodgkin lymphoma, currently recruiting i…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: TR-002 for the Treatment of Advanced, Unresectable or Metastatic Solid Tumors and Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma [Phase 1]
A Phase 1 clinical trial evaluating TR-002 for advanced unresectable or metastatic solid tumors and unresectable or metastatic pancreatic ad…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors [Phase 1]
A Phase 1 clinical trial update for a CD70-targeted CAR T therapy (CD70.CAR) in CD70-positive lymphoma, multiple myeloma, solid tumors, sarc…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities [Phase 1, Phase 2]
A Phase 1/2 clinical trial of TAS0953/HM06, a RET inhibitor, in adults with RET-altered advanced solid tumors including non-small cell lung …
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment [NA]
This clinical trial evaluates a virtually delivered diet intervention (LASO-3) intended to improve chemotherapy-induced peripheral neuropath…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers [Phase 1]
Nuvectis Pharma reports a Phase 1 clinical trial of NXP-900 in subjects with advanced cancers is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: A Study to Evaluate Safety, PK and Efficacy of GH55 in Combination With GH21 in Patients With Solid Tumors [Phase 1, Phase 2]
A phase 1/2 clinical trial to evaluate safety, pharmacokinetics, and efficacy of GH55 in combination with GH21 in patients with advanced sol…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Safety and Efficacy of CMD03 CAR T Cell in Children With Relapse or Refractory Solid Tumors [Phase 1]
Phase 1 study evaluating the safety and potential efficacy of CMD03 CAR T cells in pediatric patients with relapsed or refractory solid tumo…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors [Phase 2]
A Phase 2 clinical trial investigates sirolimus in combination with metronomic chemotherapy in children with recurrent or refractory solid t…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours [Phase 1]
Phase 1 study of the investigational therapy MBS8(1V270) evaluating safety and preliminary efficacy in patients with advanced solid tumors, …
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: First in Human Study of CDR404 in HLA-A*02:01 Participants With MAGE-A4 Expressing Solid Tumors [Phase 1]
First-in-human Phase 1 trial evaluating CDR404 in HLA-A*02:01 participants with MAGE-A4 expressing solid tumors is currently recruiting. The…